ReviewNeurology international2026

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach.

Alfonso Martinisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.